Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)

NCT01086540 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

NIH

Sponsor class

Conditions

Systemic Sclerosis-Associated PAH

Interventions

BIOLOGICAL: Rituximab
OTHER: Placebo
DIAGNOSTIC_TEST: CMRI
DRUG: prednisone
DRUG: methylprednisolone
DRUG: diphenhydramine
DRUG: acetaminophen

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]